Skip to main content
search
All Posts By

Dawn

Membership NewsMembership News Archive

Doris-Ann meets with CEO of Pathology Technology Australia

On Tuesday, Doris-Ann had the opportunity to meet with Dean Whiting, the CEO of Pathology Technology Australia (PTA). They face many similar issues to those BIVDA have, although for different reasons due to the differences in the health care systems. But certainly getting policy makers and politicians to understand that there isn’t healthcare without diagnostics supporting decision making is a…
Dawn
June 9, 2023
ConsultationsConsultations Archive

Consultation on the International Council for Harmonisation (ICH) E6 (R3) Good Clinical Practice (GCP) Guidelines

The ICH Expert Working Group (EWG) for ICH E6(R3) has been updating ICH E6(R2) GCP guidelines. The MHRA represents the Pharmaceutical Inspection Co-operation Scheme (PIC/s) in the EWG. The update is to address the application of GCP to new trial designs, technological innovations and to strengthen a proportionate risk-based approach of its application for clinical trials of medicines to support…
Dawn
June 2, 2023
HighlightsHighlights Archive

New science collaboration to drive innovation across the North West

M-SParc, Wales’ first Science Park owned by Bangor University, and AMRC Cymru have today signed an agreement to allow them to work in partnership. This will enable collaboration at all levels between the two organisations, ensuring companies receive wider access to support, skills, expertise and facilities that can drive their business forwards. M-SParc is the first dedicated science park in…
Dawn
June 2, 2023
HighlightsHighlights Archive

MHRA and Genomics England to launch pioneering biobank

A brand-new genetic research resource, known as a ‘biobank’, will be piloted by the Medicines and Healthcare products Regulatory Agency (MHRA) in a joint venture with Genomics England to better understand how a patient’s genetic makeup can impact the safety of their medicines. The Yellow Card biobank, which will contain genetic data and patient samples, will operate alongside the MHRA’s Yellow Card reporting…
Dawn
June 2, 2023
Membership NewsMembership News Archive

BBC Radio 4 programme on human microbes

In this programme, which may be of interest members, Geoff Watts visits the Human Microbiome Project, sequencing the genomes of bacteria which live on our body to discover how they affect our health. The Human Microbiome Project aims to catalogue 3,000 microbes on our body and sequence their genes. The theory is that we have co-evolved with our microbes in…
Dawn
June 2, 2023
Membership NewsMembership News Archive

IBMS release National POCT Guidance 2023

  The IBMS has collaborated with the Royal College of Pathologists (RCPath) and the Association for Clinical Biochemistry and Laboratory Medicine (ACB) to produce Point of Care Testing: National Strategic Guidance for at Point of Need Testing. The paper aims to communicate with those responsible for planning and commissioning novel patient services outside of traditional care settings. It outlines the strategic…
Dawn
June 2, 2023
Membership NewsMembership News Archive

Reports round-up: Clinical Trials and Pro-innovation Regulation of Technologies

Two important reports have been released in the last week: Lord O’Shaugnessy’s report into commercial clinical trials in the UK and Dame Angela McLean’s review into pro-innovation regulation of technologies. There are many very important recommendations in each paper which, if implemented, could have an incredibly positive effect on the industry.   Commercial clinical trials in the UK: the Lord…
Dawn
June 2, 2023
Membership NewsMembership News Archive

Doris-Ann interviewed on the IVD industry’s response to the MedTech Strategy

Medtech Insight’s Ashley Yeo interviewed Doris-Ann to better understand the UK diagnostics industry’s reaction to, and expectations of, the Government’s MedTech Strategy. Doris-Ann agreed with the instigator of the MedTech Strategy, David Lawson, that NHSE needs to improve upon its adoption of innovation at scale, simplifying the adoption process and utilising innovations more effectively. Cutting down the onerous evidence gathering…
Dawn
June 2, 2023
HighlightsHighlights Archive

Media Monitoring: 27th May – 2nd June

Theranos founder Elizabeth Holmes begins prison sentence in Texas Disgraced founder of the discredited blood testing service has been sentenced to 11 years in prison. She became a sensation when she claimed her company Theranos could scan for a range of diseases with just a few drops of blood. Despite raising almost one billion dollars from investors, she was soon…
Dawn
June 2, 2023
ConsultationsConsultations Archive

Results of the 10-Year Cancer Plan call for evidence

Here are some findings from the outcome of the 10-Year Cancer Plan consultation: 55% of individuals and 50% of professionals and organisations said that raising awareness of the causes of cancer and how it can be prevented should be prioritised over the next decade. 73% of individuals and 56% of professionals and organisations said that raising awareness of the signs…
Dawn
May 26, 2023
Close Menu